ACCP, a groundbreaking biomedical innovation, has been developed to augment drug conveyance for the cure of diverse maladies. By virtue of its distinctive activation mechanism, ACCP enables the focused intracellular dispatch of pharmaceuticals, thereby efficaciously combating conditions like cancer, genetic disorders, and viral infections. This highly versatile and therapeutically potent agent, ACCP, heralds a paradigm shift in the realm of biomedicine as it ameliorates drug effectiveness while mitigating undesired ramifications.
CAT# | GR2170 |
M.F/Formula | C63H100N22O28S |
M.W/Mr. | 1645.66 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
P11 (HSDVHK) is a novel peptide ligand containing a PDZ-binding motif (Ser-Asp-Val) with high affinity to integr ...
R18 peptide is a non-phosphorylated ligand of 14-3-3 that was originally isolated from a phage display screen, ...
Ziconotide (previously called SNX-111), currently marketed under the brand name of Prialt, is the synthetic form ...
Gonadorelin acetate, a synthetic decapeptide with sequence Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, is a gon ...
PR 39, a porcine 39-aa peptide antibiotic, was originally isolated from the upper part of the small intestine o ...